<?xml version="1.0" encoding="UTF-8"?>
<p>The authors screened many plants assuming that “adaptogens must be safe and normalize body functions irrespective of the nature of stressors” and in 1967, some were incorporated into official medical practice in the USSR as central nervous system (CNS)‐stimulating medicinal products and as tonics to fight fatigue and general weakness during convalescence for infectious diseases, chemotherapy and psychiatric disorders, after surgery, poisoning, heart attacks, ischemia, chemotherapy, and psychiatric disorders (Table 
 <xref rid="med21743-tbl-0003" ref-type="table">3</xref>). 
 <italic>Rhodiola rosea</italic> extract (Rhodiolae roseae rhizomatum et radicum extractum liquidum) is an example of an adaptogenic medicinal product used since 1975 in officinal medicine in the USSR/Russia. It is indicated for “decreased mental and physical capacities such as weakness, exhaustion, tiredness and loss of concentration, as well as during convalescence.” The extent of adaptogen research conducted in the USSR was enormous with more than 1000 pharmacological and clinical studies published in Russia until 1982.
</p>
